Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV

(2020) Jia Liu et al.   JOURNAL OF MEDICAL VIROLOGY

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

(2020) Mahmoud Gheblawi et al.   CIRCULATION RESEARCH

Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB

(2020) Juan Simon Rico-Mesa et al.   Current Cardiology Reports

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor

(2020) Yanwei Li et al.   PHARMACOLOGICAL RESEARCH

Endothelins in cardiovascular biology and therapeutics

(2019) Neeraj Dhaun et al.   Nature Reviews Cardiology

TEMPORARY REMOVAL: Blood Pressure and the New ACC/AHA Hypertension Guidelines

(2019) John M. Flack et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis

(2018) Mostafa Ebraheem Morra et al.   REVIEWS IN MEDICAL VIROLOGY

Role of the Immune System in Hypertension

(2017) Bernardo Rodriguez-Iturbe et al.   PHYSIOLOGICAL REVIEWS

Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis

(2016) Ryota Matsuyama et al.   BMC PUBLIC HEALTH

Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade

(2008) Michiya IGASE et al.   HYPERTENSION RESEARCH